Last checked at 12 Oct 2020 14:42
IN BRIEF: Destiny Pharma Set To Complete Study Recruitment By 2020 End
IN BRIEF: Destiny Pharma Set To Complete Study Recruitment By 2020 End
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Destiny Pharma. Share News (DEST)
DEST Share
Price
DEST Share
News
DEST Share
Chat3
DEST Share
Trades17
DEST
Live RNS
DEST Share
Charts
DEST Level 2
Console
DEST Live
Share Price
DEST Broker
Ratings
DEST Directors
Deals
DEST Financial
Diary
DEST
Fundamentals
DEST Short
Positions
DEST
Media
Destiny Pharma. Information
Share Price Information for Destiny Pharma. (DEST)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
18.25
Bid:
18.00
Ask:
18.50
Change:
0.00 (0.00%)
Spread:
0.50 (2.778%)
Open:
18.25
High:
18.25
Low:
18.25
Prev. Close:
18.25
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.12 Oct 2020 14:31
Second Covid wave slows patient recruitment for Destiny Pharma
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma updated the market on its 'XF-73' phase 2b clinical study with 101 patients on Monday, out of the target of 125 now recruited.
Read more17 Sep 2020 19:09
IN BRIEF: Destiny Pharma Notes XF-73 Study Recruitment On Track
IN BRIEF: Destiny Pharma Notes XF-73 Study Recruitment On Track
Read more17 Sep 2020 15:39
UK EARNINGS SUMMARY: Novacyt Profit Leaps On Covid-19 Test Kit Demand
UK EARNINGS SUMMARY: Novacyt Profit Leaps On Covid-19 Test Kit Demand
Read more7 Sep 2020 14:34
IN BRIEF: Destiny Pharma To Co-Develop Covid-19 Prevention Product
IN BRIEF: Destiny Pharma To Co-Develop Covid-19 Prevention Product
Read more7 Sep 2020 08:57
Destiny Pharma enters collaboration deal with SporeGen
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma has entered into a collaboration agreement with SporeGen, it announced on Monday, which is a UK biotechnology company working on Bacillus and its applications.
Read more11 Aug 2020 12:36
UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula
UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula
Read more27 Jul 2020 21:28
IN BRIEF: Destiny Pharma Amends Component Of XF-73 Phase 2b Trial
IN BRIEF: Destiny Pharma Amends Component Of XF-73 Phase 2b Trial
Read more15 Jul 2020 11:47
UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall
UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall
Read more9 Jun 2020 15:51
Destiny Pharma awarded grant for Cardiff research collaboration
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma has been jointly awarded a National Biofilms Innovation Centre (NBIC) grant to fund a research collaboration with Cardiff University, it announced on Tuesday.
Read more9 Jun 2020 13:25
UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
Read more3 Jun 2020 16:09
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more4 May 2020 12:24
Destiny Pharma's XF-73 Drug Candidate Backed By New Research
Destiny Pharma's XF-73 Drug Candidate Backed By New Research
Read more3 Mar 2020 16:16
Destiny Pharma Progresses On Patient Recruitment For XF-73 Study
Destiny Pharma Progresses On Patient Recruitment For XF-73 Study
Read more20 Jan 2020 11:44
Destiny Pharma Completes First Phase Of Collaboration With MedPharm
Destiny Pharma Completes First Phase Of Collaboration With MedPharm
Read more